The state of Illinois has fortified its healthcare infrastructure to ensure readiness against high-risk infectious diseases. Governor JB Pritzker announced a strategic alliance with two premier Chicago-based healthcare institutes – Rush University Medical Center and the Ann & Robert H. Lurie Children’s Hospital of Chicago. Known as Elite Special Pathogen Treatment Centers, these hospitals are set to elevate their capabilities to manage high-consequence pathogens.
High-consequence pathogens define those diseases that pose substantial public health risks, including Ebola virus, Lassa fever, and pneumonic plague. This initiative is a part of a series of measures by the Illinois Department of Public Health (IDPH) to bolster its international surveillance efforts. The move comes after the federal government’s decision to disengage from the World Health Organization (WHO) and reduce funding for the US Department of Health and Human Services.
The IDPH has allocated state funding of $900,000 to Rush University Medical Center and $600,000 to Lurie Children’s Hospital. These funds are intended to support the maintenance of airborne infection isolation rooms and facilitate investments in advanced equipment and staff training, ensuring patient safety and effective care. The partnership emphasizes Illinois’ commitment to shield public health and ensure optimal care even amidst evolving national healthcare policies.
The upgraded facilities aim to offer prompt and efficient care to Illinoisans affected by life-threatening infections. Beyond the borders of Illinois, there’s a federal network of 13 Regional Emerging Special Pathogen Treatment Centers (RESPTCs). However, none of these facilities currently exist in Illinois and closest centers are in Michigan and Minnesota. The new agreement aids Illinois to build and maintain its capacity to counter current and future global health menaces.
As Chicago houses the O’Hare International Airport, a major entry point for international travelers and the second-busiest airport in the United States, the upgraded healthcare prowess is timely and paramount. Under the agreement’s stipulations, both hospitals are mandated to maintain the capabilities to concurrently treat at least two patients suffering from a high-consequence pathogen. This includes bolstering triage and transfer protocols with other local hospitals, as well as maintaining specialized rooms and equipment and a highly-trained staff. IDPH’s partnership with these hospitals signifies a significant step towards enhancing Illinois’ capacity to respond to high-risk pathogens.
Source: https://dph.illinois.gov/content/soi/idph/en/resource-center/news/2025/june/release-20250610.html